uMed raises £9.8m to fund expansion

Health and research technology company uMed has raised £9.8m in a funding round led by Albion Capital and other venture capital investors. The move follows a $4.8m seed round in 2020. uMed said it would use the funds to extend its clinical trials in the UK and expand into the North America market. The uMed…

You must be a HM Subscriber to view this content.

Subscribe Now »